Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-04 Purchase | 2025-06-04 4:01 pm | MetaVia Inc. | MTVA | Woodworth Marshall H Chief Financial Officer | 14,200 | $0.7 | $9,940 | 44,279 (Direct) | View |
| 2025-05-08 Purchase | 2025-05-20 4:16 pm | MetaVia Inc. | MTVA | DONG-A ST CO. LTD 10% Owner | 4,647,887 | $0.71 | $3,300,000 | 9,995,679 (Direct) | View |
| 2024-09-12 Sale | 2024-09-20 4:20 pm | NeuroBo Pharmaceuticals Inc. | NRBO | DONG-A ST CO. LTD 10% Owner | 407 | $3.75 | $1,526 | 11,709,117 (Direct) | View |
| 2024-06-23 Purchase(A) | 2024-07-10 11:11 am | NeuroBo Pharmaceuticals Inc. | NRBO | DONG-A ST CO. LTD 10% Owner | 2,544,530 | $3.93 | $10,000,003 | 5,348,229 (Direct) | View |
| 2024-06-23 Purchase | 2024-06-25 4:16 pm | NeuroBo Pharmaceuticals Inc. | NRBO | DONG-A ST CO. LTD 10% Owner | 2,544,530 | $3.13 | $7,964,379 | 5,348,229 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-30 Option Award | 2025-07-01 4:03 pm | N/A N/A | MetaVia Inc. | MTVA | Glickman Mark A Director | 28,147 | $0 | 37,887 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-01 4:02 pm | N/A N/A | MetaVia Inc. | MTVA | GROVES JASON L Director | 28,147 | $0 | 45,699 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-01 4:02 pm | N/A N/A | MetaVia Inc. | MTVA | Tursi James Patrick Director | 28,147 | $0 | 37,219 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-01 4:01 pm | N/A N/A | MetaVia Inc. | MTVA | STRICKLAND D GORDON Director | 28,147 | $0 | 45,699 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-01 4:01 pm | N/A N/A | MetaVia Inc. | MTVA | KOVEN ANDREW I Director | 28,147 | $0 | 45,699 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-01 4:01 pm | N/A N/A | MetaVia Inc. | MTVA | Salsbury Michael Director | 28,147 | $0 | 45,699 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:01 pm | N/A N/A | MetaVia Inc. | MTVA | Woodworth Marshall H Chief Financial Officer | 3,417 | $1.46 | 30,079 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 4:01 pm | N/A N/A | MetaVia Inc. | MTVA | Kim Hyung Heon CEO & President | 2,795 | $1.46 | 61,004 (Direct) | View |
| 2024-11-30 Tax Withholding | 2024-12-02 5:31 pm | N/A N/A | MetaVia Inc. | MTVA | Kim Hyung Heon CEO & President | 2,867 | $2.55 | 63,799 (Direct) | View |
| 2024-08-11 Tax Withholding | 2024-08-13 4:01 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Hyung Heon CEO & President | 11,467 | $3.6 | 66,666 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-07 7:26 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Salsbury Michael Director | 5,051 | $0 | 17,552 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-07 7:26 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | GROVES JASON L Director | 5,051 | $0 | 17,552 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-07 7:25 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | KOVEN ANDREW I Director | 5,051 | $0 | 17,552 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-07 7:25 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Glickman Mark A Director | 5,051 | $0 | 9,740 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-07 7:24 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | STRICKLAND D GORDON Director | 5,051 | $0 | 17,552 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-07 7:24 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Tursi James Patrick Director | 5,051 | $0 | 9,072 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 9:20 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Woodworth Marshall H Chief Financial Officer | 33,496 | $0 | 33,496 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-04 5:12 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Tursi James Patrick Director | 32,157 | $0 | 32,157 (Direct) | View |
| 2023-08-11 Option Award | 2023-08-14 4:10 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Hyung Heon CEO & President | 625,064 | $0 | 625,064 (Direct) | View |
| 2023-07-27 Option Award | 2023-07-28 06:19 am | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | KOVEN ANDREW I Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-07-27 Option Award | 2023-07-28 06:17 am | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Salsbury Michael Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-07-27 Option Award | 2023-07-28 06:15 am | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | STRICKLAND D GORDON Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-07-27 Option Award | 2023-07-28 06:13 am | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | GROVES JASON L Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-07-27 Option Award | 2023-07-28 06:11 am | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Glickman Mark A Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-07-27 Option Award | 2023-07-28 06:08 am | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 100,000 | $0 | 302,013 (Direct) | View |
| 2022-07-26 Other(A) | 2023-07-28 06:02 am | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 4,671 | $0 | 9,342 (Indirect) | View |
Ownership | 2022-11-22 4:46 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC 10% Owner | 0 | $0 | 1,220,502 (Indirect) | View |
| 2022-07-26 Other | 2022-07-28 9:23 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | E&Investment Inc. E&Healthcare Investment Fund II 10% Owner | 1,445,267 | $0 | 7,461,936 (Indirect) | View |
| 2022-07-26 Other | 2022-07-28 4:03 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 1,445,267 | $0 | 7,365,585 (Indirect) | View |
| 2022-06-09 Option Award | 2022-06-13 4:14 pm | N/A 2032-06-09 | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:12 pm | N/A 2032-06-09 | NeuroBo Pharmaceuticals Inc. | NRBO | GROVES JASON L Director | 20,000 | $0 | 20,000 (Direct) | View |